ContraVir’s stock plunges after seesaw week of upbeat drug studies, mistaken filings and withdrawals of withdrawals – MarketWatch

ContraVir’s stock plunges after seesaw week of upbeat drug studies, mistaken filings and withdrawals of withdrawals MarketWatch

Shares of ContraVir Pharmaceuticals Inc. plunged Tuesday, to cap off a whipsaw week for investors that included upbeat results of drug studies and SEC filings …